Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Validation of a Screening Tool in Geriatric Oncology
Authors not listed
Institut Bergonié · 2008
Abstract
RATIONALE: A screening questionnaire may help doctors plan better treatment for older patients with cancer.
PURPOSE: This clinical trial is studying a questionnaire in screening older patients with cancer.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-19 MST
Cite this
APA
Anonymous. (2008). Validation of a Screening Tool in Geriatric Oncology. <em>Institut Bergonié</em>. https://clinicaltrials.gov/study/NCT00963911
Vancouver
Anonymous. Validation of a Screening Tool in Geriatric Oncology. Institut Bergonié. 2008.
BibTeX
@misc{anon2008Valida,
title = {Validation of a Screening Tool in Geriatric Oncology},
author = {Anonymous},
journal = {Institut Bergonié},
year = {2008},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Ziekenhuis Netwerk Antwerpen (ZNA) 2009
Open access · US-GOV
Impact of Frailty in Senior Cancer Patients: Feasibility and Value of Screening Tools and Geriatric Intervention and Predictive Value of a Screening Tool in Relation to Treatment Outcome
Hospital de Braga 2026
Open access · US-GOV
Prospective Validation of the G8 Geriatric Screening Tool in Older Adults With Cancer in Portugal (G8-PT Study)
Ju Qiu 2023
Open access · US-GOV
Comparison of Frailty Screening Performance and Predictive Validity of Adverse Health Outcomes in Breast Cancer Patients Using Frailty Screening Tools
Peking University People's Hospital 2018
Open access · US-GOV
The Value of Geriatric Assessments in Predicting Treatment Tolerance and Overall Survival in Older Patients With Breast Cancer.
Ankara Etlik City Hospital 2025
Open access · US-GOV
FRAIL and FiND for Assessing Severe Chemotherapy Toxicity Risk in Older Adults With Gastrointestinal Cancer Receiving Adjuvant Chemotherapy
Nature 2024
Preprint · OA